Homepage
Medication Guide
How to Purchase Adempas (Riociguat Tablets)
Adempas (Riociguat Tablets) is a soluble guanylate cyclase stimulant, primarily indicated for the treatment of chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension...
506
Wednesday, December 3rd, 2025, 09:40
Dosage and Administration of Crizotinib
Crizotinib is a multi-target tyrosine kinase inhibitor, primarily indicated for the treatment of ALK-positive or ROS1-positive non-small cell lung cancer (NSCLC), ALK-positive anaplastic large cell ly...
512
Wednesday, December 3rd, 2025, 09:34
Dosage and Administration of Relugolix
Relugolix is an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, often formulated as a fixed-dose combination with estrogens (e.g., estradiol) and progestogens (e.g., norethindrone acet...
511
Wednesday, December 3rd, 2025, 09:30
What Are the Purchase Channels for Relugolix?
Relugolix is an innovative gonadotropin-releasing hormone (GnRH) receptor antagonist, which has shown significant efficacy in the treatment of heavy menstrual bleeding associated with uterine fibroids...
510
Wednesday, December 3rd, 2025, 09:27
Precautions for Adagrasib Administration
Adagrasib is an irreversible inhibitor of KRASG12C, primarily indicated for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) and colorectal cancer (CRC) with KRASG12C...
509
Wednesday, December 3rd, 2025, 09:25
What Are the Indications of Relugolix?
Relugolix is an oral medication, often used in combination with estradiol and norethindrone acetate to form the fixed-dose combination product relugolix. It is mainly indicated for the treatment of he...
508
Wednesday, December 3rd, 2025, 09:22
Side Effects of Adagrasib
Adagrasib is an irreversible inhibitor of KRASG12C mutation, indicated for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) and colorectal cancer (CRC) with KRASG12C ...
506
Wednesday, December 3rd, 2025, 09:19
Dosage and Administration of Adagrasib
Adagrasib is an irreversible inhibitor of KRASG12C mutation, mainly used for the treatment of non-small cell lung cancer (NSCLC) and colorectal cancer (CRC) with specific gene mutations.Dosage and Adm...
521
Wednesday, December 3rd, 2025, 09:14
What Are the Indications of Adagrasib?
Adagrasib is an innovative KRASG12C inhibitor, which was first approved for marketing in the United States in 2022. As a major breakthrough in the field of targeted therapy, this medication provides a...
507
Tuesday, December 2nd, 2025, 11:20
What Are the Purchase Channels for Adagrasib?
Adagrasib is an innovative KRASG12C-targeted inhibitor that has shown promising efficacy in the treatment of non-small cell lung cancer and colorectal cancer.What Are the Purchase Channels for Adagras...
508
Tuesday, December 2nd, 2025, 11:15
45 / 214
2139 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved